Distribution of Immunoglobulin G Subclasses of Anti-thyroid Peroxidase Antibody in Sera from Patients with Hashimoto's Thyroiditis with Different Thyroid Functional Status

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 2008 Sep 10

PMID 18778360

Citations 9

Authors

L-D Xie

Y Gao

M-R Li

G-Z Lu

X-H Guo

Affiliations

Soon will be listed here.

Abstract

The mechanism of disease progression in Hashimoto's thyroiditis (HT) is still unclear. Anti-thyroid peroxidase antibody (TPOAb), a diagnostic hallmark of HT, is principally of the immunoglobulin G (IgG) isotype, and it appears to be a response to thyroid injury. The aim of our study was to evaluate the distribution of IgG subclasses of TPOAb in sera from patients with HT with different thyroid functional status. Sera from 168 patients with newly diagnosed HT were collected and divided into three groups according to thyroid function: patients with hypothyroidism (n = 66), subclinical hypothyroidism (n = 60) and euthyroidism (n = 42). Antigen-specific enzyme-linked immunosorbent assay was used to detect the distribution of TPOAb IgG subclasses. The prevalence of TPOAb IgG subclasses in all patients' sera with HT was IgG1 70.2%, IgG2 35.1%, IgG3 19.6% and IgG4 66.1% respectively. The prevalence of IgG2 in sera from patients with hypothyroidism (51.5%) was significantly higher than that of subclinical hypothyroidism (33.3%) (P < 0.05), and the latter was also significantly higher than that of euthyroidism (11.9%) (P < 0.05). The positive percentage of IgG2 subclass in sera from patients with hypothyroidism and subclinical hypothyroidism was significantly higher than that of euthyroidism (P < 0.05), the prevalence and positive percentage of IgG4 subclass in sera from patients with hypothyroidism and subclinical hypothyroidism was significantly higher than that of euthyroidism respectively (P < 0.05). The predominant TPOAb IgG subclasses in sera from patients with HT were IgG1 and IgG4. Patients with high levels of TPOAb IgG2, IgG4 subclasses might be at high risk of developing overt hypothyroidism.

Citing Articles

Thyroid Autoimmunity During Universal Salt Iodisation-Possible Short-Term Modulation with Longer-Term Stability.

Atapattu N, Jayatissa R, de Silva H, Adlan M, Obuobie E, Premawardhana L Nutrients. 2025; 16(24.

PMID: 39770919 PMC: 11677496. DOI: 10.3390/nu16244299.

Difficulties in the Diagnostics and Treatment of Hashimoto's Encephalopathy-A Systematic and Critical Review.

Pempera N, Miedziaszczyk M, Lacka K Int J Mol Sci. 2024; 25(13).

PMID: 39000209 PMC: 11241003. DOI: 10.3390/ijms25137101.

Hashimoto Encephalopathy-Still More Questions than Answers.

Waliszewska-Prosol M, Ejma M Cells. 2022; 11(18).

PMID: 36139446 PMC: 9496753. DOI: 10.3390/cells11182873.

[Value of ultrasound shear wave elasticity imaging in diagnosis of Hashimoto's thyroiditis].

Wang W, Zheng H, Wang Q, Han Y, Ye Q, Wen C Nan Fang Yi Ke Da Xue Xue Bao. 2017; 37(5):683-686.

PMID: 28539295 PMC: 6780460.

Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases.

Frohlich E, Wahl R Front Immunol. 2017; 8:521.

PMID: 28536577 PMC: 5422478. DOI: 10.3389/fimmu.2017.00521.

References

Silva L, Chavez J, Canalli M, Zanetti C . Determination of IgG subclasses and avidity of antithyroid peroxidase antibodies in patients with subclinical hypothyroidism - a comparison with patients with overt hypothyroidism. Horm Res. 2003; 59(3):118-24. DOI: 10.1159/000069069. View

Vanderpump M, Tunbridge W, French J, Appleton D, Bates D, Clark F . The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf). 1995; 43(1):55-68. DOI: 10.1111/j.1365-2265.1995.tb01894.x. View

Bogner U, Hegedus L, Hansen J, Finke R, Schleusener H . Thyroid cytotoxic antibodies in atrophic and goitrous autoimmune thyroiditis. Eur J Endocrinol. 1995; 132(1):69-74. DOI: 10.1530/eje.0.1320069. View

Burton D . Immunoglobulin G: functional sites. Mol Immunol. 1985; 22(3):161-206. DOI: 10.1016/0161-5890(85)90151-8. View

McLachlan S, Feldt-Rasmussen U, Young E, MIDDLETON S, Date J, Carr D . IgG subclass distribution of thyroid autoantibodies: a 'fingerprint' of an individual's response to thyroglobulin and thyroid microsomal antigen. Clin Endocrinol (Oxf). 1987; 26(3):335-46. DOI: 10.1111/j.1365-2265.1987.tb00791.x. View

Weetman A, Black C, Cohen S, Tomlinson R, Banga J, Reimer C . Affinity purification of IgG subclasses and the distribution of thyroid auto-antibody reactivity in Hashimoto's thyroiditis. Scand J Immunol. 1989; 30(1):73-82. DOI: 10.1111/j.1365-3083.1989.tb01190.x. View

Guo J, Jaume J, Rapoport B, McLachlan S . Recombinant thyroid peroxidase-specific Fab converted to immunoglobulin G (IgG) molecules: evidence for thyroid cell damage by IgG1, but not IgG4, autoantibodies. J Clin Endocrinol Metab. 1997; 82(3):925-31. DOI: 10.1210/jcem.82.3.3831. View

Dayan C, Daniels G . Chronic autoimmune thyroiditis. N Engl J Med. 1996; 335(2):99-107. DOI: 10.1056/NEJM199607113350206. View

Bruggemann M, Williams G, Bindon C, Clark M, Walker M, Jefferis R . Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies. J Exp Med. 1987; 166(5):1351-61. PMC: 2189658. DOI: 10.1084/jem.166.5.1351. View

10.

Kawano Y, Noma T, Yata J . Regulation of human IgG subclass production by cytokines. IFN-gamma and IL-6 act antagonistically in the induction of human IgG1 but additively in the induction of IgG2. J Immunol. 1994; 153(11):4948-58. View

11.

Duncan A, Winter G . The binding site for C1q on IgG. Nature. 1988; 332(6166):738-40. DOI: 10.1038/332738a0. View

12.

Rodien P, Madec A, Ruf J, Rajas F, Bornet H, Carayon P . Antibody-dependent cell-mediated cytotoxicity in autoimmune thyroid disease: relationship to antithyroperoxidase antibodies. J Clin Endocrinol Metab. 1996; 81(7):2595-600. DOI: 10.1210/jcem.81.7.8675583. View

13.

Phenekos C, Vryonidou A, Gritzapis A, Baxevanis C, Goula M, Papamichail M . Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' disease (Th2). Neuroimmunomodulation. 2004; 11(4):209-13. DOI: 10.1159/000078438. View

14.

Schur P . IgG subclasses--a review. Ann Allergy. 1987; 58(2):89-96, 99. View

15.

Chiovato L, Bassi P, Santini F, Mammoli C, Lapi P, Carayon P . Antibodies producing complement-mediated thyroid cytotoxicity in patients with atrophic or goitrous autoimmune thyroiditis. J Clin Endocrinol Metab. 1993; 77(6):1700-5. DOI: 10.1210/jcem.77.6.7903315. View

16.

Davies T, Platzer M . The T cell suppressor defect in autoimmune thyroiditis: evidence for a high set 'autoimmunostat'. Clin Exp Immunol. 1986; 63(1):73-9. PMC: 1577347. View

17.

Wadeleux P, Ruf J, Carayon P, WINAND R . Cytotoxic assay of circulating thyroid peroxidase antibodies. Autoimmunity. 1989; 4(4):247-54. DOI: 10.3109/08916938909014701. View

18.

Metcalfe R, Jordan N, Watson P, Gullu S, Wiltshire M, Crisp M . Demonstration of immunoglobulin G, A, and E autoantibodies to the human thyrotropin receptor using flow cytometry. J Clin Endocrinol Metab. 2002; 87(4):1754-61. DOI: 10.1210/jcem.87.4.8411. View

19.

Waldmann H . Manipulation of T-cell responses with monoclonal antibodies. Annu Rev Immunol. 1989; 7:407-44. DOI: 10.1146/annurev.iy.07.040189.002203. View

20.

Parkes A, McLachlan S, Bird P, Rees Smith B . The distribution of microsomal and thyroglobulin antibody activity among the IgG subclasses. Clin Exp Immunol. 1984; 57(1):239-43. PMC: 1536069. View